Vanguard disaggregates holdings; reports 0 shares of QuidelOrtho (QDEL)
Rhea-AI Filing Summary
QuidelOrtho Corp received an amended Schedule 13G/A from The Vanguard Group stating that, following an internal realignment, Vanguard reports 0 shares beneficially owned of QuidelOrtho common stock.
The filing explains certain subsidiaries will report disaggregated ownership separately in reliance on SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Vanguard report for QDEL ownership in this amendment?
Direct answer: The amendment states 0 shares beneficially owned by The Vanguard Group. Context: The filing notes an internal realignment and that certain Vanguard subsidiaries will report ownership separately in reliance on SEC Release No. 34-39538.
Does the Schedule 13G/A show any voting or dispositive power for Vanguard?
Direct answer: The filing shows 0 sole and 0 shared voting and dispositive powers. Context: Item 4 lists zero for sole/shared power to vote and dispose, and beneficial ownership percentage as 0% of the class.
Who signed the amendment for Vanguard and when was it signed?
Direct answer: The amendment is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026. Context: The signature block on the Schedule 13G/A provides the name, title, and signature date associated with the filing.